CDC issued a new health advisory for the rare liver damage in children. The latest warning against unexplained hepatitis was announced so that public health authorities would be more cautious.
The international health agency released the new Health Alert Network (HAN) Health Advisory on Thursday, Apr. 21. As of writing, CDC identified nine rare liver damage cases in Alabama.
On the other hand, dozens of cases were detected in the United States, Netherlands, Spain, the United Kingdom, and the Netherlands.
CDC Issues Health Advisory for Rare Liver Damage in Children
According to NBC News' latest report, the rare liver damage is actually well-known hepatitis. However, the cause of the latest cases is unknown.
Also Read : CDC's First Batch of COVID-19 Tests are Flawed? Internal Investigation Reveals Possible Contamination
"This Health Advisory serves to notify US clinicians who may encounter pediatric patients with hepatitis of unknown etiology," said CDC via its official health advisory.
The agency also urges health experts to consider adenovirus testing since some of the individuals who have acute liver failure were tested have the disease.
The Centers for Disease Control and Prevention added that medical facilities need to disclose the data they acquire from patients with rare liver damage.
Symptoms and Other Details
CDC explained that the rare liver damage condition could lead to nausea, vomiting, abdominal pain, and diarrhea. If your children experience some of these symptoms, it is advisable to bring them to the nearest doctor to be observed.
On the other hand, the health agency also provided its suggestions that health experts are highly encouraged to follow:
- Health facilities need to consider conducting adenovirus testing.
- Pediatric experts are advised to conduct NAAT.
- CDC explained that whole testing blood via PCR is more effective than testing plasma. But, if the hepatitis patients don't have the rare liver damage condition, PCR plasma testing can be considered.
If you want to see more details about CDC's latest health advisory, you can visit this link.
Recently, the distribution date of the updated Moderna COVID-19 Omicron vaccine has been confirmed.
Meanwhile, the new COVID-19 breath test was finally approved by FDA.
For more news updates about CDC and other related health topics, always keep your tabs open here at TechTimes.
Related Article : CDC Warns US About New Incurable Superbug Fungus; Can It Spread From Patient to Patient?
This article is owned by TechTimes
Written by: Griffin Davis
